BioGaia AB (publ)
BIOG-B
Rangering i aksjer
#7836
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Aksjekurs
$13.86
Sist synkronisert: 2026-10-16
Markedsverdi
$1.37B
Endring (1 dag)
0.65%
Endring (1 år)
23.21%
Land
SE
Handel BioGaia AB (publ) (BIOG-B)
Kategori
Healthcare
Markedsverdi av BioGaia AB (publ)(BIOG-B)
Markedsverdi: $1.37B
Per October 2026 har BioGaia AB (publ) en markedsverdi på $1.37B. Dette gjør BioGaia AB (publ) til det 7836th mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for BioGaia AB (publ) fra 2015 til 2026
BIOG-B sammenlignet med topp 5 mest populære stocks
